D&D Pharmatech (347850) has 61 disclosed insider purchases and 10 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩2.8B ($1.9M) in reported transaction value. The earliest filing StockDrifts holds for D&D Pharmatech is dated 2024-05-02; the most recent is 2026-10-23. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -46.72%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-10-23 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 5 | - | - | - |
| 2026-06-04 | BUY | 주식매수청구권 행사 | 박평아 Park Pyeong-ah | Managing Director | 2.4K | ₩94,000 | -12.2% | ₩226M ($157K) |
| 2026-06-04 | BUY | 주식매수청구권 행사 | 신재희 Jaehee Shin | moving | 56.0K | ₩94,000 | -12.2% | ₩5.3B ($3.7M) |
| 2026-06-04 | BUY | 주식매수청구권 행사 | 임성묵 Seongmuk Lim | Managing Director | 38.0K | ₩94,000 | -12.2% | ₩3.6B ($2.5M) |
| 2026-05-13 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 300 | ₩68,200 | -1.3% | ₩20M ($14K) |
| 2026-05-11 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 40 | ₩70,700 | -4.8% | ₩3M ($2K) |
| 2026-05-08 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 60 | ₩70,800 | -4.9% | ₩4M ($3K) |
| 2026-05-04 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 100 | ₩74,900 | -10.2% | ₩7M ($5K) |
| 2026-04-30 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 500 | ₩74,200 | -9.3% | ₩37M ($26K) |
| 2026-04-28 | SELL | Market Sell | 한설희 Seolhee Han | Outside Director | -125 | ₩78,700 | +14.5% | ₩10M ($7K) |
| 2026-04-27 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 15 | ₩81,800 | -17.7% | ₩1M ($852) |
| 2026-04-24 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 10 | ₩81,800 | -17.7% | ₩818K ($568) |
| 2026-04-23 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 100 | ₩79,700 | -15.6% | ₩8M ($6K) |
| 2026-04-20 | SELL | Market Sell | 한설희 Seolhee Han | Outside Director | -228 | ₩82,000 | +17.9% | ₩19M ($13K) |
| 2026-04-17 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 12 | ₩78,900 | -14.7% | ₩947K ($658) |
| 2026-04-16 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 486 | ₩81,600 | -17.5% | ₩40M ($28K) |
| 2026-04-15 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 30 | ₩79,800 | -15.7% | ₩2M ($2K) |
| 2026-04-13 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 50 | ₩76,400 | -11.9% | ₩4M ($3K) |
| 2026-04-10 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 46 | ₩74,000 | -9.1% | ₩3M ($2K) |
| 2026-04-09 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 44 | ₩68,700 | -2.0% | ₩3M ($2K) |
| 2026-04-08 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 54 | ₩69,800 | -3.6% | ₩4M ($3K) |
| 2026-04-07 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 6 | ₩67,600 | -0.4% | ₩406K ($282) |
| 2026-04-06 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 200 | ₩66,300 | +1.5% | ₩13M ($9K) |
| 2026-04-03 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 8 | ₩68,600 | -1.9% | ₩549K ($381) |
| 2026-04-02 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 12 | ₩69,400 | -3.0% | ₩833K ($578) |
| 2026-04-01 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 70 | ₩74,900 | -10.2% | ₩5M ($4K) |
| 2026-03-26 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 10 | ₩78,500 | -14.3% | ₩785K ($545) |
| 2026-03-25 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 100 | ₩79,100 | -14.9% | ₩8M ($5K) |
| 2026-03-23 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 47 | ₩70,300 | -4.3% | ₩3M ($2K) |
| 2026-03-20 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 138 | ₩78,100 | -13.8% | ₩11M ($7K) |
| 2026-03-19 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 65 | ₩78,900 | -14.7% | ₩5M ($4K) |
| 2026-03-17 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 50 | ₩83,500 | -19.4% | ₩4M ($3K) |
| 2026-03-13 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 100 | ₩92,300 | -27.1% | ₩9M ($6K) |
| 2026-03-11 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 100 | ₩80,200 | -16.1% | ₩8M ($6K) |
| 2026-03-06 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 90 | ₩83,900 | -19.8% | ₩8M ($5K) |
| 2026-03-05 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 360 | ₩82,200 | -18.1% | ₩30M ($21K) |
| 2026-02-26 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 20 | ₩88,800 | -24.2% | ₩2M ($1K) |
| 2026-02-25 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 30 | ₩88,700 | -24.1% | ₩3M ($2K) |
| 2026-02-24 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 98 | ₩88,600 | -24.0% | ₩9M ($6K) |
| 2026-02-23 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 202 | ₩86,500 | -22.2% | ₩17M ($12K) |
| 2026-02-20 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 100 | ₩84,900 | -20.7% | ₩8M ($6K) |
| 2026-02-10 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 200 | ₩79,200 | -15.0% | ₩16M ($11K) |
| 2026-02-06 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 200 | ₩77,500 | -13.2% | ₩16M ($11K) |
| 2026-02-03 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 299 | ₩90,300 | -25.5% | ₩27M ($19K) |
| 2026-01-28 | SELL | Market Sell | 한설희 Seolhee Han | Outside Director | -2.0K | ₩99,300 | +32.2% | ₩199M ($138K) |
| 2026-01-26 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 500 | ₩96,700 | -30.4% | ₩48M ($34K) |
| 2026-01-23 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 300 | ₩85,800 | -21.6% | ₩26M ($18K) |
| 2026-01-22 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 300 | ₩79,300 | -15.1% | ₩24M ($17K) |
| 2026-01-21 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 200 | ₩80,100 | -16.0% | ₩16M ($11K) |
| 2026-01-20 | BUY | Market Buy | 한설희 Seolhee Han | Outside Director | 100 | ₩89,700 | -25.0% | ₩9M ($6K) |
Showing the 50 most recent of 97 filings.
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for D&D Pharmatech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.